Eugenia Gianos, M.D. | Risk Assistent and Treatment of Lipid Disorders
This presentation by Dr. Eugenia Gianos explores advanced lipid management, emphasizing lifestyle as the primary intervention. It covers risk assessment for cardio-kidney-metabolic disease, genetic dyslipidemias, and the evolving landscape of lipid-modifying agents, including statins and PCSK9 inhibitors. The discussion highlights the importance of personalized treatment strategies and addressing residual cardiovascular risk. Visit our website: texasheart.org
▶︎
Christie M. Ballantyne, M.D. | Prevention and Treatment of Cardiometabolic Disease
▶︎
I Treat Cholesterol Differently Now: Statins, PCSK9s, Ezetimibe & Gene Editing
▶︎
2026 Spring Poster Showcase Transplant & Health Services
▶︎
Ajith Nair, M.D. | Cardiac Myosin Inhibitors and Hypertrophic Cardiomyopathy: A Paradigm Shift?
▶︎
Improving Cervical Cancer Elimination in Canada with Genotyping and Self-Sampling
▶︎
Mahboob Alam, M.D. | Left Main Coronary Disease Interventions
▶︎
New Dyslipidemia Guidelines: Aligning Science and Care
▶︎
How I Use Statins to Unclog Arteries
▶︎
Juan Lopez-Mattei, M.D. | Advanced Cardiac Imaging in Patients With Cancer.
▶︎
Lp(a) Explained: Genetics, Risk, and What You Can Actually Do
▶︎
Reverse Heart Disease Through Diet with Dr. Michael Greger
▶︎
Stone Gregg, M.D.: Cardiovascular Innovation and Future
▶︎
2026 Spring Clinical Meetings A Deep Dive into Bone Disease in CKD
▶︎
High Lp(a)? Here's What Works (And What Doesn't)
▶︎
Rebecca T. Hahn, M.D. | Transformative Approaches to Tricuspid Regurgitation
▶︎
May 2026 - Research Spotlight with Dr. DeMayo and Dr. Sochet
▶︎
Srihari S. Naidu, M.D. | Cardiogenic Shock: The Journey to Improved Survival
▶︎
Dr. Jarushka Naidoo, Lung
▶︎
5 STEPS — AND YOUR CHOLESTEROL IS BACK TO NORMAL! LOWERED MY CHOLESTEROL WITHOUT A SINGLE PILL
▶︎